SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-18-043724
Filing Date
2018-08-13
Accepted
2018-08-13 07:45:13
Documents
2
Period of Report
2018-08-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 tv500805_form3.html 3  
1 FORM 3 tv500805_form3.xml 3 1550
2 EXHIBIT 24.1 tv500805_ex24-1.htm EX-24.1 5186
  Complete submission text file 0001144204-18-043724.txt   8297
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Issuer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 6225 NEIL ROAD RENO NV 89511
Business Address
Granot David (Reporting) CIK: 0001551620 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33357 | Film No.: 181010271